logo
  

Staples CEO Ronald Sargent's 2014 Total Compensation Up 15% To $12.39 Mln

Office supplies retailer Staples Inc. (SPLS) disclosed in a regulatory filing that its Chief Executive officer Ronald Sargent received a 2014 total compensation that was about 15 percent higher than the prior year, while his base salary remained unchanged in 2014 as well as 2013.

The increase in total compensation for its CEO in 2014 from 2013 was primarily due to the payment in 2014 of an annual cash incentive award earned under the Amended and Restated Executive Officer Incentive Plan. No annual cash incentive award was earned in 2013. The increase in total compensation for its CEO in 2013 and 2014 as compared to 2012 was primarily related to a change in the form of incentive awards granted to its NEOs.

Sargent received a total compensation of $12.39 million, including base salary, stock grants and incentives in 2014, compared to the $10.77 million he received in 2013, and $6.47 million he got in 2012.

The total compensation received by Sargent in 2014 includes $1.25 million as base salary, $8.23 million as stock grants, and non-equity incentive plan compensation of $2.59 million.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Consumer Product Safety Commission or CPSC has announced recalls including earmuffs, racer car toys, log splitters and cylinder kits, hampshire cribs, and air rifles, citing various reasons. 3M Co. has recalled Peltor X4 Series Earmuffs citing risk of overexposure to loud noise and sound, while Santa Monica, California -based JAKKS Pacific Inc. has called back children's Mario Kart... Lincoln Park, New Jersey -based ConSup North America Inc. is recalling around 85,984 pounds of ready-to-eat or RTE sliced prosciutto ham product produced in Germany without the benefit of equivalent inspection, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq.

A busy week for economics saw the release of first quarter growth figures for the U.S. economy and the interest rate decision in Japan. Read our stories to find out why the GDP data damped market sentiment in the U.S. and what were the signals given out by the Bank of Japan. Other news this week included new home sales data and jobless claims figures from the U.S., and the latest purchasing managers' survey results for the Eurozone.

View More Videos
Follow RTT